04 67 20 77 30

contact@sensorion-pharma.com

A team committed to the development of a therapeutic portfolio in hearing loss

WHO ARE WE ?

Sensorion is a pioneering clinical-stage biotech company, dedicated to the development of innovative therapies to restore, treat and prevent within the field of hearing loss

Amit Munshi

Chairman of the Board, Independent Director and Interim CEO
  • 35 years of experience in the healthcare industry
  • Previously served as CEO of Orna Therapeutics, ReNagade Therapeutics and Arena Therapeutics
  • Executive leadership having led multiple biotech companies to successful transformational growth milestones and exits
  • Occupied multiple roles in Big Pharma

Géraldine Honnet, M.D.

Chief Medical Officer
  • 25 years in clinical development and gene therapy
  • Formerly Director of Development, Genethon and Medical Director, Parexel International
  • Previously Senior Clinical Manager, Transgene

Bernd Schmidt

Chief Technical Officer
  • 20 years’ experience in life sciences
  • CMC expert
  • Formerly Vice President Product Delivery at Quell Therapeutics and MPD Leader at GSK Stevenage

Laurene Danon

Chief Financial Officer
  • 15 years of experience in investment banking and international equity capital markets.
  • Formerly Senior Banker at Jefferies and J.P. Morgan

Stéphanie Filipe

Head of Business Operations & Portfolio Management
  • 20 years in therapeutic products development in Biotechs from bench to beside including gene and cell therapies
  • Formerly R&D Director at OTR3, Program Leader at Cellectis
  • Ph.D., Cellular Biology & Biochemistry

Laurent Désiré

Head of Preclinical Development
  • Over 20 years in pharmaceutical R&D and clinical development, especially in gene therapy and neuroscience
  • Formerly Head of Cellular and Molecular Biology unit at YposKesi, and R&D Executive Director at Diaxonhit and ExonHit
  • Ph.D., Biology of Aging

Christine Le Bec

Head of CMC Gene Therapy
  • 25 years in production process development for gene therapy
  • Formerly Head of CMC analytical department, Genethon
  • Ph.D., Biochemistry and Analytical Chemistry

Valérie Salentey

Director of Regulatory Affairs & Quality Assurance
  • Over 15 years in Regulatory Affairs and Quality Assurance in Biologics and advanced therapies
  • Formerly headed Regulatory Affairs at Cytheris, Généthon, PPD, Neovacs
  • Doctor of Pharmacy (PharmD)

Rachel Cooper

Head of Audiology
  • Over 23 years in the hearing health industry
  • Formerly Global Professional Marketing Manager at Cochlear Ltd.
  • Doctor of Audiology (AuD), Cochlear Implant Specialty Certification (CISC), Pediatric Audiology Specialty Certification (PASC), Executive MBA

Amit Munshi

Chairman of the Board, Independent Director and Interim CEO
  • 35 years of experience in the healthcare industry
  • Previously served as CEO of Orna Therapeutics, ReNagade Therapeutics and Arena Therapeutics
  • Executive leadership having led multiple biotech companies to successful transformational growth milestones and exits
  • Occupied multiple roles in Big Pharma

Khalil Barrage

Director Representative of Invus
  • 20 years of experience in portfolio management at The Olayan Group in New York
  • Managing Director for the Invus Group in New York and Board member of Protagenic and Celtaxsys

Julien Miara

Director, Representative of Invus
  • 10 years of experience in investment, covering biotechnology among other sectors
  • Director at Invus

Cédric Moreau

Director representing Sofinnova Partners
  • 18 years of experience in investment banking and in life sciences
  • Partner in the Crossover investment team at Sofinnova Partners

Natalie Berner

Director representing Redmile Group
  • Managing Director specializing in therapeutic products at Redmile
  • Former Research Associate at New York University School of Medicine
  • Bachelor’s degree in Community Health from Brown University and Certificate in Premedical Sciences from Columbia University
  • Member of two other boards: Redx Pharma and BioInvent

Eric de la Fortelle

Independent Director
  • 10 years of experience as scientific researcher in biotechnology, CEO and member of several Boards
  • Venture Partner at Seventure Partners

Aniz Girach

Independent Director
  • M.D., over 22 years’ experience in the pharma industry
  • CMO at ProQR Therapeutics
  • Member of three Scientific Advisory Boards

Florian Reinaud

Board Observer Redmile Group
  • Special Advisor Europe for Redmile Group
  • 20 years experience in Healthcare Innovation and Capital Investment
  • Former emergency physician in the UK’s National Health Service
  • MD., awarded with Distinction from Imperial College London and holds a BA(hons) in Physiology from the University of Oxford
  • Board Member of Sensome

Federico Mingozzi, Ph.D.

Independant Director
  • More than 25 years experience in gene therapy, immunology, as well as biochemistry and
    molecular biology
  • Previously Chief Science and Technology at Spark Therapeutics
  • He holds a bachelor’s degree in biology and a Ph.D. in biochemistry and molecular biology from the
    University of Ferrara in Italy, and a M.B.A. from Drexel University.

Pr Christine Petit

Chair of the Scientific Advisory Board
  • Chair of Genetics and Cellular Physiology,  Professor at College de France and at Institut Pasteur (Paris)
  • Head of the Laboratory of Genetics and Physiology of Hearing  at Institut Pasteur
  • Managing Director of the French Hearing Institute
  • Member of the French and American Sciences Academies  and the American Medical Academy

Pr Alain Fischer

  • Professor at College de France
  • Former director and founding member of the Institute for Genetic Diseases (Imagine)
  • Former director of the pediatric immuno-hematology department at Necker Hospital

Dr Robert Dow

  • More than 37 years of experience in the pharmaceutical and biotech industry
  • Former Chief Medical Officer at PPD Inc.
  • Substantial experience across therapeutic areas from pre-clinical to Phase 3 development

Pr Paul Avan

  • Physicist and Medical Doctor in Biophysics
  • Head of the Center for Research and Innovation in Human Audiology at Hearing Institute (Paris)
  • Designed original objective methods of exploration of the cochlea and auditory pathways

Dr. Diane Lazard

  • ENT Surgeon and former Head of Clinic at AP-HP
  • Principal Associate Investigator at the Hearing Institute (Paris)
  • Currently pursuing research on deciphering language processing variability in deafness

Dr. Hernán López-Schier

  • Senior Group Leader and Research Unit Director at the Helmholtz Center in Munich
  • Currently pursuing research on fundamental sensory biology and sensory dysfunction
  • His group was the first to visualize the regeneration of mechanosensory hair cells in their natural context